Adlai Nortye Group Ltd. balance sheet
At the end of fiscal 2025, Adlai Nortye Group Ltd. had total assets of $34.4m, total liabilities of $42.8m and shareholders' equity of −$8.3m. It held $8.1m in cash against $24.6m of debt: net debt of $16.5m.
Balance sheet
| Fiscal year | 2021Dec 2021 | 2023Dec 2023 | 2025Dec 2025 |
|---|---|---|---|
| Cash and equivalents | 64 | 91 | 8 |
| Total current assets | — | 101 | 27 |
| Total assets | — | 130 | 34 |
| Total current liabilities | — | 50 | 42 |
| Short-term debt | — | 30 | 25 |
| Total debt | 10 | 30 | 25 |
| Total liabilities | — | 55 | 43 |
| Shareholders' equity | −185 | 75 | −8 |
| Net debt (negative = net cash) | −54 | −61 | 17 |
Compare with peers
- Inventiva S.a. balance sheet
- Rani Therapeutics Holdings, Inc. balance sheet
- Immuron Ltd balance sheet
- Bolt Biotherapeutics, Inc. balance sheet
- Entrada Therapeutics, Inc. balance sheet
Head to head: ANL vs IVAANL vs RANIANL vs IMRN
More: Biotechnology stocks compared, Health Care sector, rankings of US companies